Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8759 |
High Similarity |
NPD6651 |
Approved |
0.8599 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8476 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8411 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8261 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8148 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8141 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8072 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8039 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7987 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7836 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7688 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7688 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7683 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7661 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7643 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7443 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7425 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7403 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7401 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7399 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3748 |
Approved |
0.733 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7322 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7322 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.729 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7273 |
Intermediate Similarity |
NPD920 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7233 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7225 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7219 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7134 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7016 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7016 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7016 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7005 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6982 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD3226 |
Approved |
0.6979 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6979 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD7228 |
Approved |
0.6962 |
Remote Similarity |
NPD3268 |
Approved |
0.6947 |
Remote Similarity |
NPD6782 |
Approved |
0.6947 |
Remote Similarity |
NPD6778 |
Approved |
0.6947 |
Remote Similarity |
NPD6780 |
Approved |
0.6947 |
Remote Similarity |
NPD6777 |
Approved |
0.6947 |
Remote Similarity |
NPD6776 |
Approved |
0.6947 |
Remote Similarity |
NPD6779 |
Approved |
0.6947 |
Remote Similarity |
NPD6781 |
Approved |
0.6943 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6932 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6928 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6914 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD7003 |
Approved |
0.6875 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6872 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD2309 |
Approved |
0.686 |
Remote Similarity |
NPD37 |
Approved |
0.6859 |
Remote Similarity |
NPD2797 |
Approved |
0.6857 |
Remote Similarity |
NPD919 |
Approved |
0.6855 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD7801 |
Approved |
0.6848 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD4965 |
Approved |
0.6839 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD4966 |
Approved |
0.6821 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6813 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6805 |
Remote Similarity |
NPD6273 |
Approved |
0.6802 |
Remote Similarity |
NPD7874 |
Approved |
0.6802 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6798 |
Remote Similarity |
NPD8366 |
Approved |
0.6788 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD7585 |
Approved |
0.6782 |
Remote Similarity |
NPD4288 |
Approved |
0.6778 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD6535 |
Approved |
0.6772 |
Remote Similarity |
NPD6534 |
Approved |
0.6771 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD6234 |
Discontinued |
0.676 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD1203 |
Approved |
0.6748 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6747 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6742 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6735 |
Remote Similarity |
NPD7583 |
Approved |
0.6731 |
Remote Similarity |
NPD4749 |
Approved |
0.6727 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6727 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6727 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6718 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6718 |
Remote Similarity |
NPD8319 |
Approved |
0.671 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6709 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD5890 |
Approved |
0.6705 |
Remote Similarity |
NPD5889 |
Approved |
0.6704 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6688 |
Remote Similarity |
NPD8651 |
Approved |
0.6685 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6685 |
Remote Similarity |
NPD1247 |
Approved |
0.6667 |
Remote Similarity |
NPD9717 |
Approved |
0.6667 |
Remote Similarity |
NPD8491 |
Approved |
0.6667 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD3972 |
Approved |
0.6667 |
Remote Similarity |
NPD2403 |
Approved |
0.6667 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6649 |
Remote Similarity |
NPD4287 |
Approved |
0.6647 |
Remote Similarity |
NPD2654 |
Approved |
0.6646 |
Remote Similarity |
NPD3267 |
Approved |
0.6646 |
Remote Similarity |
NPD3266 |
Approved |
0.6635
|
Remote Similarity |
NPD8469 |
Approved |